drugset / Trial / NCT02039050

Evaluation of Long-Acting Muscarinic Antagonists in COPD

NCT02039050

Phase 4 Completed 15 enrolled University of Dundee Almirall Limited · collab
RandomizedCrossoverOpen-labelTreatment

Summary

In chronic obstructive pulmonary disease (COPD), the airways of the lungs are narrowed or blocked. Bronchodilators are drugs usually delivered through inhalers which help open up the airways. Tiotropium is a type of bronchodilator drug known as a long-acting muscarinic antagonist (LAMA). For a long time tiotropium was the only available LAMA. More recently, a new LAMA called aclidinium has been approved for use in COPD. There are potentially important differences between these two medications that might have an impact on the treatment of COPD patients. In this study we aim to compare the effects of tiotropium and aclidinium in people with COPD. The main comparison will be done using a very sensitive breathing test called impulse oscillometry

Timeline

Start
2014-02
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Aclidinium Small molecule 322 ug Inhaled
Comparator Tiotropium Other / unclassified 18 ug Inhaled